Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant
dc.contributor.author | Shimizu, Ritsuko | en_US |
dc.contributor.author | Kobayashi, Eri | en_US |
dc.contributor.author | Engel, James Douglas | en_US |
dc.contributor.author | Yamamoto, Masayuki | en_US |
dc.date.accessioned | 2010-06-01T22:17:14Z | |
dc.date.available | 2010-06-01T22:17:14Z | |
dc.date.issued | 2009-09 | en_US |
dc.identifier.citation | Shimizu, Ritsuko; Kobayashi, Eri; Engel, James Douglas; Yamamoto, Masayuki (2009). "Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant." Genes to Cells 14(9): 1119-1131. <http://hdl.handle.net/2027.42/75300> | en_US |
dc.identifier.issn | 1356-9597 | en_US |
dc.identifier.issn | 1365-2443 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75300 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19682090&dopt=citation | en_US |
dc.format.extent | 696057 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | Journal compilation © 2009 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd | en_US |
dc.title | Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Genetics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109-220, USA | en_US |
dc.contributor.affiliationother | Department of Experimental Hematology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan | en_US |
dc.contributor.affiliationother | Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan | en_US |
dc.identifier.pmid | 19682090 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75300/1/j.1365-2443.2009.01338.x.pdf | |
dc.identifier.doi | 10.1111/j.1365-2443.2009.01338.x | en_US |
dc.identifier.source | Genes to Cells | en_US |
dc.identifier.citedreference | Ahmed, M., Sternberg, A., Hall, G., Thomas, A., Smith, O., O’Marcaigh, A., Wynn, R., Stevens, R., Addison, M., King, D., Stewart, B., Gibson, B., Roberts, I. & Vyas, P. ( 2004 ) Natural history of GATA1 mutations in Down syndrome. Blood 103, 2480 – 2489. | en_US |
dc.identifier.citedreference | Bozner, P. ( 2002 ) Transient myeloproliferative disorder with erythroid differentiation in Down syndrome. Arch. Pathol. Lab. Med. 126, 474 – 477. | en_US |
dc.identifier.citedreference | Calligaris, R., Bottardi, S., Cogoi, S., Apezteguia, I. & Santoro, C. ( 1995 ) Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Proc. Natl Acad. Sci. USA 92, 11598 – 11602. | en_US |
dc.identifier.citedreference | Chang, A.N., Cantor, A.B., Fujiwara, Y., Lodish, M.B., Droho, S., Crispino, J.D. & Orkin, S.H. ( 2002 ) GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc. Natl Acad. Sci. USA 14, 9237 – 9242. | en_US |
dc.identifier.citedreference | Dubart, A., Romeo, P.H., Vainchenker, W. & Dumenil, D. ( 1996 ) Constitutive expression of GATA-1 interferes with the cell-cycle regulation. Blood 87, 3711 – 3721. | en_US |
dc.identifier.citedreference | Fujiwara, Y., Browne, C.P., Cunniff, K., Goff, S.C. & Orkin, S.H. ( 1996 ) Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl Acad. Sci. USA 93, 12355 – 12358. | en_US |
dc.identifier.citedreference | Greene, M.E., Mundschau, G., Wechsler, J., McDevitt, M., Gamis, A., Karp, J., Gurbuxani, S., Arceci, R. & Crispino, J.D. ( 2003 ) Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. Blood Cells Mol. Dis. 31, 351 – 356. | en_US |
dc.identifier.citedreference | Harigae, H., Xu, G., Sugawara, T., Ishikawa, I., Toki, T. & Ito, E. ( 2004 ) The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome. Blood 103, 3242 – 3243. | en_US |
dc.identifier.citedreference | Hitzler, J.K., Cheung, J., Li, Y., Scherer, S.W. & Zipursky, A. ( 2003 ) GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 101, 4301 – 4304. | en_US |
dc.identifier.citedreference | Hollanda, L.M., Lima, C.S., Cunha, A.F., Albuquerque, D.M., Vassallo, J., Ozelo, M.C., Joazeiro, P.P., Saad, S.T. & Costa, F.F. ( 2006 ) An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis. Nat. Genet. 18, 807 – 812. | en_US |
dc.identifier.citedreference | Holmes, D.K., Bates, N., Murray, M., Ladusans, E.J., Morabito, A., Bolton-Maggs, P.H., Johnston, T.A., Walkenshaw, S., Wynn, R.F. & Bellantuono, I. ( 2006 ) Hematopoietic progenitor cell deficiency in fetuses and children affected by Down’s syndrome. Exp. Hematol. 34, 1611 – 1615. | en_US |
dc.identifier.citedreference | Ito, E., Kasai, M., Hayashi, Y., Toki, T., Arai, K., Yokoyama, S., Kato, K., Tachibana, N., Yamamoto, M. & Yokoyama, M. ( 1995 ) Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down’s syndrome. Br. J. Haematol. 90, 607 – 614. | en_US |
dc.identifier.citedreference | Ito, E., Toki, T., Ishihara, H., Ohtani, H., Gu, L., Yokoyama, M., Engel, J.D. & Yamamoto, M. ( 1993 ) Erythroid transcription factor GATA-1 is abundantly transcribed in mouse testis. Nature 362, 466 – 468. | en_US |
dc.identifier.citedreference | Karandikar, N.J., Aquino, D.B., McKenna, R.W. & Kroft, S.H. ( 2001 ) Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis. Am. J. Clin. Pathol. 116, 204 – 210. | en_US |
dc.identifier.citedreference | Kaushansky, K. ( 1995 ) Thrombopoietin: the primary regulator of platelet production. Blood 86, 419 – 431. | en_US |
dc.identifier.citedreference | Kuhl, C., Atzberger, A., Iborra, F., Nieswandt, B., Porcher, C. & Vyas, P. ( 2005 ) GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1. Mol. Cell. Biol. 25, 8592 – 8606. | en_US |
dc.identifier.citedreference | Levine, R.F. & Fedorko, M.E. ( 1976 ) Isolation of intact megakaryocytes from guinea pig femoral marrow. Successful harvest made possible with inhibitions of platelet aggregation; enrichment achieved with a two-step separation technique. J. Cell Biol. 69, 159 – 172. | en_US |
dc.identifier.citedreference | Li, Z., Godinho, F.J., Klusmann, J.H., Garriga-Canut, M., Yu, C. & Orkin, S.H. ( 2005 ) Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat. Genet. 37, 613 – 619. | en_US |
dc.identifier.citedreference | Massey, G.V. ( 2005 ) Transient leukemia in newborns with Down syndrome. Pediatr. Blood Cancer 44, 29 – 32. | en_US |
dc.identifier.citedreference | Nishimura, S., Takahashi, S., Kuroha, T., Suwabe, N., Nagasawa, T., Trainor, C. & Yamamoto, M. ( 2000 ) A GATA box in the GATA-1 gene hematopoietic enhancer is a critical element in the network of GATA factors and sites that regulate this gene. Mol. Cell. Biol. 20, 713 – 723. | en_US |
dc.identifier.citedreference | Onodera, K., Takahashi, S., Nishimura, S., Ohta, J., Motohashi, H., Yomogida, K., Hayashi, N., Engel, J.D. & Yamamoto, M. ( 1997 ) GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis. Proc. Natl Acad. Sci. USA 94, 4487 – 4492. | en_US |
dc.identifier.citedreference | Pan, X., Ohneda, O., Ohneda, K., Lindeboom, F., Iwata, F., Shimizu, R., Nagano, M., Suwabe, N., Philipsen, S., Lim, K.C., Engel, J.D. & Yamamoto, M. ( 2005 ) Graded levels of GATA-1 expression modulate survival, proliferation and differentiation of erythroid progenitors. J. Biol. Chem. 6, 22385 – 22394. | en_US |
dc.identifier.citedreference | Rainis, L., Bercovich, D., Strehl, S., Teigler-Schlegel, A., Stark, B., Trka, J., Amariglio, N., Biondi, A., Muler, I., Rechavi, G., Kempski, H., Haas, O.A. & Izraeli, S. ( 2003 ) Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 102, 981 – 986. | en_US |
dc.identifier.citedreference | Shimizu, R., Engel, J.D. & Yamamoto, M. ( 2008 ) GATA1-related leukaemias. Nat. Rev. Cancer 8, 279 – 287. | en_US |
dc.identifier.citedreference | Shimizu, R., Kuroha, T., Ohneda, O., Pan, X., Ohneda, K., Takahashi, S., Philipsen, S. & Yamamoto, M. ( 2004a ) Leukemogenesis caused by incapacitated GATA-1 function. Mol. Cell. Biol. 24, 10814 – 10825. | en_US |
dc.identifier.citedreference | Shimizu, R., Ohneda, K., Engel, J.D., Trainor, C.D. & Yamamoto, M. ( 2004b ) Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia. Blood 103, 2560 – 2567. | en_US |
dc.identifier.citedreference | Shimizu, R., Takahashi, S., Ohneda, K., Engel, J.D. & Yamamoto, M. ( 2001 ) In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis. EMBO J. 20, 5250 – 5260. | en_US |
dc.identifier.citedreference | Takahashi, S., Onodera, K., Motohashi, H., Suwabe, N., Hayashi, N., Yanai, N., Nabesima, Y. & Yamamoto, M. ( 1997 ) Arrest in primitive erythroid cell development caused by promoter-specific disruption of the GATA-1 gene. J. Biol. Chem. 272, 12611 – 12615. | en_US |
dc.identifier.citedreference | Tober, J., Koniski, A., McGrath, K.E., Vemishetti, R., Emerson, R., de Mesy-Bentley, K.K., Waugh, R. & Palis, J. ( 2007 ) The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis. Blood 109, 1433 – 1441. | en_US |
dc.identifier.citedreference | Ugazio, A.G., Maccario, R., Notarangelo, L.D. & Burgio, G.R. ( 1990 ) Immunology of Down syndrome: a review. Am. J. Med. Genet. Suppl. 7, 204 – 212. | en_US |
dc.identifier.citedreference | Vannucchi, A.M., Bianchi, L., Cellai, C., Paoletti, F., Rana, R.A., Lorenzini, R., Migliaccio, G. & Migliaccio, A.R. ( 2002 ) Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood 100, 1123 – 1132. | en_US |
dc.identifier.citedreference | Wechsler, J., Greene, M., McDevitt, M.A., Anastasi, J., Karp, J.E., Le Beau, M.M. & Crispino, J.D. ( 2002 ) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat. Genet. 12, 1 – 5. | en_US |
dc.identifier.citedreference | Weiss, M.J. & Orkin, S.H. ( 1995 ) Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc. Natl Acad. Sci. USA 92, 9623 – 9627. | en_US |
dc.identifier.citedreference | Xu, M.J., Matsuoka, S., Yang, F.C., Ebihara, Y., Manabe, A., Tanaka, R., Eguchi, M., Asano, S., Nakahata, T. & Tsuji, K. ( 2001 ) Evidence for the presence of murine primitive megakaryocytopoiesis in the early yolk sac. Blood 97, 2016 – 2022. | en_US |
dc.identifier.citedreference | Zipursky, A. ( 2003 ) Transient leukaemia – a benign form of leukaemia in newborn infants with trisomy 21. Br. J. Haematol. 120, 930 – 938. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.